Evolent Cash from 2010 to 2024

EVH Stock  USD 12.92  0.01  0.08%   
Evolent Health's Cash is increasing with slightly volatile movements from year to year. Cash is predicted to flatten to about 176.4 M. Cash is the total amount of money in the form of currency that Evolent Health has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2013-12-31
Previous Quarter
121.3 M
Current Value
96.6 M
Quarterly Volatility
87.7 M
 
Yuan Drop
 
Covid
Check Evolent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolent Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129.6 M, Total Revenue of 2.1 B or Gross Profit of 483.5 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0072 or PTB Ratio of 3.61. Evolent financial statements analysis is a perfect complement when working with Evolent Health Valuation or Volatility modules.
  
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.

Latest Evolent Health's Cash Growth Pattern

Below is the plot of the Cash of Evolent Health over the last few years. Cash refers to the most liquid asset of Evolent Health, which is listed under current asset account on Evolent Health balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Evolent Health customers. The amounts must be unrestricted with restricted cash listed in a different Evolent Health account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Evolent Health's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolent Health's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Evolent Cash Regression Statistics

Arithmetic Mean140,733,590
Geometric Mean73,216,549
Coefficient Of Variation75.22
Mean Deviation86,771,084
Median145,726,000
Standard Deviation105,865,944
Sample Variance11207.6T
Range335.2M
R-Value0.76
Mean Square Error5168.6T
R-Squared0.57
Significance0
Slope17,900,014
Total Sum of Squares156906.4T

Evolent Cash History

2024176.4 M
2023192.8 M
2022188.2 M
2021266.3 M
2020340.5 M
2019101 M
2018228.3 M

Other Fundumenentals of Evolent Health

Evolent Health Cash component correlations

About Evolent Health Financial Statements

Investors use fundamental indicators, such as Evolent Health's Cash, to determine how well the company is positioned to perform in the future. Although Evolent Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Cash192.8 M176.4 M
Cash And Short Term Investments192.8 M196.3 M
Cash And Equivalents216.4 M231.9 M
Change In Cash8.3 MM
Free Cash Flow113.8 M119.5 M
Begin Period Cash Flow215.2 M229 M
Other Cashflows From Financing Activities104.3 M63.3 M
Other Non Cash Items101.1 M106.1 M
Total Cash From Operating Activities142.6 M149.7 M
Total Cash From Financing Activities281.3 M295.4 M
End Period Cash Flow223.5 M217.3 M
Total Cashflows From Investing Activities-233.2 M-221.5 M
Other Cashflows From Investing Activities-266.1 M-252.8 M
Cash And Cash Equivalents Changes-125.2 M-119 M
Cash Flows Other Operating-16.3 M-17.1 M
Free Cash Flow Yield 0.03  0.03 
Operating Cash Flow Per Share 1.28  1.35 
Free Cash Flow Per Share 1.02  1.07 
Cash Per Share 1.73  1.65 
Capex To Operating Cash Flow 0.20  0.21 
EV To Operating Cash Flow 28.94  30.39 
EV To Free Cash Flow 36.25  38.06 
Price To Operating Cash Flows Ratio 25.77  27.06 
Price To Free Cash Flows Ratio 32.28  33.89 
Cash Ratio 0.29  0.27 
Cash Conversion Cycle 71.32  74.88 
Operating Cash Flow Sales Ratio 0.07  0.08 
Free Cash Flow Operating Cash Flow Ratio 0.80  1.46 
Cash Flow Coverage Ratios 0.23  0.25 
Price Cash Flow Ratio 25.77  27.06 
Cash Flow To Debt Ratio 0.23  0.25 

Currently Active Assets on Macroaxis

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out the analysis of Evolent Health Correlation against competitors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evolent Health. If investors know Evolent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evolent Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.92)
Revenue Per Share
21.554
Quarterly Revenue Growth
0.216
Return On Assets
0.0073
Return On Equity
(0.06)
The market value of Evolent Health is measured differently than its book value, which is the value of Evolent that is recorded on the company's balance sheet. Investors also form their own opinion of Evolent Health's value that differs from its market value or its book value, called intrinsic value, which is Evolent Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evolent Health's market value can be influenced by many factors that don't directly affect Evolent Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.